Showing results (41-50 of 1,238) with videos related to
Sort By:
Pageof 124
Transplantation|April 1, 1987
Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow graftsD Bunjes, W Heit, R Arnold, et al.Bone Marrow Transplantation|March 1, 1995
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMTB Hertenstein, W Hampl, D Bunjes, et al.Scandinavian Journal of Infectious Diseases|January 1, 1988
Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantationT Schmeiser, E Kurrle, R Arnold, et al.Bone Marrow Transplantation|April 1, 1995
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexateD Bunjes, B Hertenstein, M Wiesneth, et al.Blut|October 1, 1982
Impaired T-cell and NK-cell function in patients with preleukemiaF Porzsolt, H HeimpelDeutsche Medizinische Wochenschrift (1946)|May 18, 1979
[Drugs and acute agranulocytosis: analysis of previous drug intake in 42 patients (author's transl)]H Heimpel, C AbtTransplantation|November 1, 1993
Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantationB Hertenstein, M Wiesneth, J Novotny, et al.Annals of Hematology|January 1, 1994
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropeniaB Hertenstein, W V Kern, T Schmeiser, et al.Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
[Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation]M Wiesneth, B Hertenstein, D Bunjes, et al.Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
ABO-incompatible bone marrow transplantationM Wiesneth, B Hertenstein, D Bunjes, et al.Pageof 124